35 related articles for article (PubMed ID: 2011926)
1. Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.
Chatterjee G; Gujral S; Subramanian PG; Tembhare PR
Indian J Hematol Blood Transfus; 2017 Sep; 33(3):303-315. PubMed ID: 28824230
[TBL] [Abstract][Full Text] [Related]
2. The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.
Alexandrakis MG; Passam FH; Dambaki C; Pappa CA; Stathopoulos EN
J Clin Pathol; 2004 Aug; 57(8):856-60. PubMed ID: 15280408
[TBL] [Abstract][Full Text] [Related]
3. Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade.
Xu JL; Lai R; Kinoshita T; Nakashima N; Nagasaka T
J Clin Pathol; 2002 Jul; 55(7):530-4. PubMed ID: 12101201
[TBL] [Abstract][Full Text] [Related]
4. Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.
Dolbeare F
Histochem J; 1995 Dec; 27(12):923-64. PubMed ID: 8789396
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
Greipp PR; Lust JA
Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
[TBL] [Abstract][Full Text] [Related]
7. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
[TBL] [Abstract][Full Text] [Related]
10. bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: a comparative study.
Miguel-García A; Orero T; Matutes E; Carbonell F; Miguel-Sosa A; Linares M; Tarín F; Herrera M; García-Talavera J; Carbonell-Ramón F
Haematologica; 1998 Apr; 83(4):298-304. PubMed ID: 9592978
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
